GO:0003676 nucleic acid binding: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0003676 nucleic acid binding is a molecular function defined as binding to a nucleic acid, encompassing both DNA and RNA interactions.
• Nucleic acid binding is mediated by electrostatic, hydrogen-bonding, and base-stacking interactions, often involving positively charged residues that contact the phosphodiester backbone.
• Key protein families include zinc-finger proteins such as CNBP, viral nucleocapsid proteins, and prion protein PrP, each with distinct nucleic acid binding modes.
• Dysregulation of nucleic acid binding is linked to cancer, neurodegeneration, and viral replication, making it a major therapeutic target.
• Experimental approaches include CRISPR knockout, point mutation, knock-in, and overexpression models, combined with binding assays and structural methods.
• Computational tools such as protein language modeling and MM-GBSA are increasingly used to predict nucleic acid binding sites and affinities.
Description
Nucleic acid binding (GO:0003676) is a fundamental molecular function that underpins nearly every aspect of gene expression, genome maintenance, and RNA metabolism. Proteins with this activity interact with DNA or RNA through a combination of electrostatic, hydrogen-bonding, and stacking interactions, enabling processes such as transcription, replication, splicing, and translation. The importance of nucleic acid binding is underscored by its involvement in viral replication, where proteins like the HIV-1 nucleocapsid protein chaperone nucleic acid folding, and in neurodegeneration, where prion protein PrP binds nucleic acids and may mobilize retroelements. Understanding the molecular basis of nucleic acid binding is therefore critical for both basic biology and therapeutic development.
nucleic acid binding At A Glance
| GO ID | GO:0003676 |
|---|---|
| GO term | nucleic acid binding |
| Ontology | molecular_function |
| Synonym | base pairing |
| Major function | Binding to DNA or RNA, enabling processes such as transcription, replication, and RNA metabolism |
| Definition | Binding to a nucleic acid. |
| Related functions | DNA binding, RNA binding, sequence-specific DNA binding, single-stranded DNA binding |
| Representative proteins | CNBP, HIV-1 nucleocapsid protein, prion protein PrP, CPV NSP9 |
What Is GO:0003676?
According to the Gene Ontology, nucleic acid binding (GO:0003676) is defined as the binding to a nucleic acid, which includes both DNA and RNA molecules. This molecular function is characterized by non-covalent interactions between a protein or other molecule and a nucleic acid polymer, often involving sequence-specific or structure-specific recognition. The synonym base pairing reflects one common mode of interaction, where complementary bases form hydrogen bonds.
Why Is nucleic acid binding Important in Cell Biology?
Nucleic acid binding is essential for the regulation of gene expression and the maintenance of genome integrity, and its dysfunction is implicated in a wide range of human diseases, including cancer, viral infections, and neurodegenerative disorders. Proteins that bind nucleic acids are also key targets for drug discovery, as exemplified by antiretroviral therapies targeting HIV-1 nucleocapsid protein and by efforts to modulate prion protein interactions. Moreover, advances in computational modeling and high-throughput screening are accelerating the identification of small molecules and peptides that can specifically disrupt or enhance nucleic acid binding.
• Nucleic acid binding is required for transcription, replication, and repair of DNA.
• RNA-binding proteins control splicing, stability, and translation of mRNAs.
• Viral proteins such as HIV-1 nucleocapsid protein use nucleic acid binding for packaging and replication.
• Prion protein PrP binds nucleic acids and may contribute to retroelement mobilization in transmissible spongiform encephalopathy.
• CNBP is a conserved nucleic acid binding protein with roles in development and disease.
• Dysregulation of nucleic acid binding is associated with cancer and neurodegeneration.
• Nucleic acid binding dyes are used as photocatalysts in polymerization, showing broader applications.
• Computational prediction of nucleic acid binding sites aids drug design.
• Peptide nucleic acid binding enthalpies can be modeled to guide antisense therapeutics.
• Crystal structures of viral nucleic acid binding proteins inform antiviral strategies.
Molecular Mechanism of nucleic acid binding
Substrate recognition and binding interface
In simple terms: Proteins recognize nucleic acids by matching shape and chemical properties.
Nucleic acid binding typically begins with the recognition of specific structural features or sequences in DNA or RNA. Proteins often use positively charged patches to interact with the negatively charged phosphodiester backbone, while aromatic residues stack with bases. For example, the HIV-1 nucleocapsid protein uses zinc fingers to bind single-stranded nucleic acids with high affinity. CNBP, a CCHC-type zinc finger protein, binds both DNA and RNA, and its binding is modulated by metal ions and redox state.
Conformational changes and induced fit
In simple terms: Binding often changes the shape of both the protein and the nucleic acid.
Upon binding, proteins and nucleic acids can undergo conformational changes that stabilize the complex. The HIV-1 nucleocapsid protein chaperones nucleic acid folding, facilitating strand annealing and rearrangement. Similarly, prion protein PrP binding to nucleic acids can induce structural transitions that may promote aggregation or retroelement mobilization. These dynamic changes are critical for function and are often studied using NMR, crystallography, and molecular dynamics simulations.
Cofactors and metal ions
In simple terms: Metal ions and cofactors help proteins bind nucleic acids correctly.
Many nucleic acid binding proteins require metal ions such as zinc for structural integrity. Zinc-finger proteins like CNBP rely on zinc coordination to fold properly and bind nucleic acids. The HIV-1 nucleocapsid protein also contains zinc fingers that are essential for its nucleic acid chaperone activity. Other cofactors, such as ATP, can modulate binding in helicases and chaperones.
Regulation of nucleic acid binding
In simple terms: Cells control when and where proteins bind nucleic acids.
Nucleic acid binding is regulated at multiple levels, including post-translational modifications (e.g., phosphorylation), subcellular localization, and interaction with partner proteins. For instance, the activity of CNBP can be modulated by redox state and metal availability. In viruses, nucleic acid binding by nucleocapsid proteins is temporally regulated during maturation. Computational models can predict how mutations affect binding affinity, aiding in the design of inhibitors.
Kinetics and thermodynamics of binding
In simple terms: Binding strength and speed determine biological outcomes.
The affinity and kinetics of nucleic acid binding are governed by electrostatic and hydrophobic interactions, as well as by the flexibility of the interacting partners. Techniques such as isothermal titration calorimetry and surface plasmon resonance are used to measure binding constants. Molecular modeling, including MM-GBSA, can estimate binding enthalpies for peptide nucleic acid complexes, providing insights for antisense drug design.
Key Genes Involved in GO:0003676 nucleic acid binding
The following genes and proteins represent key examples of nucleic acid binding molecules with diverse functions and research relevance.
| Gene | Major Role | Research Relevance |
|---|---|---|
| CNBP | CCHC-type zinc finger nucleic acid binding protein; binds DNA and RNA | Implicated in development, cancer, and neurodegeneration |
| HIV-1 NC | Nucleocapsid protein; chaperones nucleic acid folding | Antiviral target; model for RNA binding |
| PRNP | Prion protein; binds nucleic acids and may mobilize retroelements | Neurodegeneration; transmissible spongiform encephalopathy |
| CPV NSP9 | Non-structural protein 9; binds nucleic acids in viroplasm | Viral replication; Reovirales |
| TARDBP | TDP-43; RNA-binding protein | Amyotrophic lateral sclerosis; frontotemporal dementia |
| FUS | RNA-binding protein | ALS; RNA metabolism |
| HNRNPA1 | Heterogeneous nuclear ribonucleoprotein A1; RNA binding | Cancer; splicing regulation |
| PABPC1 | Poly(A) binding protein; binds mRNA | Translation; stability |
| EIF4E | Cap-binding protein; binds mRNA cap | Translation initiation; cancer |
| TP53 | p53; sequence-specific DNA binding | Tumor suppressor; cancer |
| SP1 | Transcription factor; binds GC-rich DNA | Gene regulation; cancer |
| NFKB1 | NF-kB; DNA binding | Inflammation; cancer |
| STAT3 | Signal transducer; DNA binding | Cancer; immune regulation |
| MYC | Transcription factor; binds DNA | Cancer; cell cycle |
| SOX2 | Transcription factor; DNA binding | Stemness; cancer |
| OCT4 | POU5F1; DNA binding | Pluripotency; reprogramming |
| NANOG | Homeobox transcription factor; DNA binding | Stemness |
| CTCF | Insulator protein; DNA binding | Chromatin organization |
How Is nucleic acid binding Regulated?
Nucleic acid binding is regulated by post-translational modifications, such as phosphorylation and acetylation, which can alter protein conformation or charge and thus affect nucleic acid affinity. Metal ion availability, particularly zinc, modulates the folding and activity of zinc-finger proteins like CNBP. In viruses, nucleic acid binding by nucleocapsid proteins is temporally controlled during maturation. Additionally, interaction with partner proteins and non-coding RNAs can sequester or stabilize nucleic acid binding proteins, adding another layer of regulation.
nucleic acid binding and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| TP53 | Cancer (Li-Fraumeni syndrome, many sporadic cancers) | Knockout and point mutation in cancer cell lines |
| PRNP | Transmissible spongiform encephalopathy | Knockout and knock-in in mouse models |
| TARDBP | Amyotrophic lateral sclerosis | Overexpression and point mutation in neuronal cells |
| FUS | Amyotrophic lateral sclerosis | Knockout and knock-in in iPSC-derived neurons |
| HIV-1 NC | HIV/AIDS | Point mutation in viral clones; overexpression in producer cells |
Nucleic acid binding in cancer
Many transcription factors and RNA-binding proteins that bind nucleic acids are dysregulated in cancer. For example, mutations in TP53 impair its sequence-specific DNA binding, leading to loss of tumor suppressor function. Overexpression of RNA-binding proteins such as HNRNPA1 can alter splicing patterns that promote tumor progression. Targeting nucleic acid binding interfaces with small molecules is a promising therapeutic strategy.
Nucleic acid binding in neurodegeneration
Prion protein PrP binds nucleic acids and may facilitate retroelement mobilization, contributing to transmissible spongiform encephalopathy. Similarly, TDP-43 and FUS, which are RNA-binding proteins, form pathological aggregates in ALS and frontotemporal dementia. Disruption of nucleic acid binding by these proteins is thought to contribute to disease pathogenesis.
Nucleic acid binding in viral infections
Viral proteins such as HIV-1 nucleocapsid protein and CPV NSP9 are essential for viral replication and packaging through their nucleic acid binding activities. These proteins are attractive antiviral targets, and structural studies have informed the design of inhibitors that block nucleic acid binding.
From nucleic acid binding-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of nucleic acid binding affect cell viability? | CRISPR knockout of the gene in relevant cell line |
| Does a specific point mutation alter binding affinity? | Point mutation knock-in via CRISPR |
| Does tagging the protein affect its localization? | Knock-in of fluorescent or epitope tag |
| Does overexpression drive oncogenic transformation? | Overexpression via lentiviral transduction |
| Can a drug disrupt nucleic acid binding? | Knockout plus drug treatment in cell-based assay |
| What are the genome-wide binding sites? | Knock-in of tagged protein followed by ChIP-seq or CLIP-seq |
How to Study the nucleic acid binding Process
| Method | What It Measures | Typical Application |
|---|---|---|
| EMSA | Protein-nucleic acid complex formation | Qualitative binding and specificity |
| SPR | Binding kinetics (kon, koff, KD) | Quantitative affinity measurements |
| ITC | Binding enthalpy and stoichiometry | Thermodynamic characterization |
| X-ray crystallography | 3D structure of complex | Atomic details of binding interface |
| ChIP-seq | Genome-wide DNA binding sites | Transcription factor mapping |
| CLIP-seq | Transcriptome-wide RNA binding sites | RNA-binding protein targets |
| CRISPR screen | Gene essentiality or drug response | Identify modifiers of nucleic acid binding |
Binding assays
Electrophoretic mobility shift assay (EMSA) and surface plasmon resonance (SPR) are used to measure nucleic acid binding affinity and specificity. Isothermal titration calorimetry (ITC) provides thermodynamic parameters. These methods are often combined with mutagenesis to map binding interfaces.
Structural biology
X-ray crystallography and cryo-electron microscopy reveal atomic details of protein-nucleic acid complexes. NMR spectroscopy is valuable for studying dynamic interactions and conformational changes. Computational docking and molecular dynamics simulations complement experimental structures.
Genome-wide mapping
ChIP-seq, CLIP-seq, and related techniques identify binding sites across the genome or transcriptome. These methods require specific antibodies or tagged proteins, which can be generated via CRISPR knock-in.
Functional screens
CRISPR library screens can identify genes whose knockout alters nucleic acid binding-dependent processes, such as viral replication or drug sensitivity. High-throughput sequencing readouts quantify guide RNA enrichment.
How CRISPR Can Be Used to Study GO:0003676 nucleic acid binding
Knockout
CRISPR knockout of genes encoding nucleic acid binding proteins can reveal their essential roles in cell proliferation, survival, and disease models. For example, knocking out TP53 in cancer cell lines abrogates DNA binding and tumor suppressor function. Knockout of viral nucleic acid binding proteins, such as HIV-1 NC, impairs viral replication.
Point Mutation
Point mutations can be introduced to dissect the contribution of specific residues to nucleic acid binding. For instance, mutating zinc-coordinating cysteines in CNBP abolishes nucleic acid binding and alters its function. Such models are valuable for understanding disease-associated mutations.
Knock-in
Knock-in of tags (e.g., GFP, HA) or disease-relevant mutations allows tracking of endogenous proteins and their binding dynamics. Tagged knock-in models are particularly useful for ChIP-seq and CLIP-seq to map binding sites.
Overexpression
Overexpression of nucleic acid binding proteins can mimic pathological states, such as cancer or neurodegeneration. For example, overexpression of TDP-43 in neuronal cells recapitulates aspects of ALS. Overexpression models are also used to study viral proteins like HIV-1 NC.
How EDITGENE Supports nucleic acid binding Research
Researchers studying nucleic acid binding-related genes often need to determine whether a candidate gene is causally involved in a specific biological process or disease. This requires precise genetic manipulation, which can be achieved through CRISPR-based knockout, point mutation, knock-in, or overexpression models. EDITGENE provides end-to-end services to generate such models and to screen for modifiers using CRISPR libraries and bioinformatics.
Contact EDITGENE today to design your custom CRISPR model for nucleic acid binding research.
Frequently Asked Questions About nucleic acid binding
What is nucleic acid binding (GO:0003676)?
Nucleic acid binding is a molecular function defined as binding to a nucleic acid, including both DNA and RNA.
What genes are involved in nucleic acid binding?
Many genes encode nucleic acid binding proteins, including CNBP, PRNP, TP53, TARDBP, FUS, and viral genes like HIV-1 NC.
What diseases are associated with nucleic acid binding defects?
Diseases include cancer, neurodegeneration (e.g., ALS, prion disease), and viral infections such as HIV/AIDS.
How can I study nucleic acid binding in the lab?
Common methods include EMSA, SPR, ITC, X-ray crystallography, ChIP-seq, CLIP-seq, and CRISPR screens.
What is the role of zinc fingers in nucleic acid binding?
Zinc fingers are structural motifs that coordinate zinc ions and facilitate nucleic acid binding, as seen in CNBP and HIV-1 NC.
Can CRISPR be used to study nucleic acid binding?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models are widely used to dissect nucleic acid binding functions.
What is the synonym for GO:0003676?
The synonym is base pairing.
How is nucleic acid binding regulated?
It is regulated by post-translational modifications, metal ions, subcellular localization, and protein-protein interactions.
What computational tools predict nucleic acid binding?
Protein language modeling and MM-GBSA are used to predict binding sites and affinities.
Why is nucleic acid binding important for drug discovery?
Many drugs target nucleic acid binding proteins, such as antiretrovirals against HIV-1 NC and potential anticancer agents against transcription factors.
Conclusion
Nucleic acid binding (GO:0003676) is a central molecular function that governs gene expression, genome stability, and viral replication. Its dysregulation contributes to cancer, neurodegeneration, and infectious diseases, making it a prime target for therapeutic intervention. Advances in structural biology, computational modeling, and CRISPR-based genetic engineering are providing unprecedented insights into the mechanisms and regulation of nucleic acid binding. Continued research in this area promises to yield new diagnostics and treatments for a wide range of human disorders.
References
- 1. Gromiha MM et al.. 2025. Protein-nucleic acid complexes: Docking and binding affinity.. Curr Opin Struct Biol 90:102955 PMID: 39616716
- 2. Jeong J et al.. 2024. Nucleic Acid-Binding Dyes as Versatile Photocatalysts for Atom-Transfer Radical Polymerization.. J Am Chem Soc 146(19):13598-13606 PMID: 38691811
- 3. Mouhand A et al.. 2020. Overview of the Nucleic-Acid Binding Properties of the HIV-1 Nucleocapsid Protein in Its Different Maturation States.. Viruses 12(10) PMID: 33003650
- 4. Armas P et al.. 2021. What's new about CNBP? Divergent functions and activities for a conserved nucleic acid binding protein.. Biochim Biophys Acta Gen Subj 1865(11):129996 PMID: 34474118
- 5. Wang B et al.. 2024. Advances in the Application of Protein Language Modeling for Nucleic Acid Protein Binding Site Prediction.. Genes (Basel) 15(8) PMID: 39202449
- 6. Lathe R et al.. 2020. Prion protein PrP nucleic acid binding and mobilization implicates retroelements as the replicative component of transmissible spongiform encephalopathy.. Arch Virol 165(3):535-556 PMID: 32025859
- 7. Wang Y et al.. 2024. Crystal structure and nucleic acid binding mode of CPV NSP9: implications for viroplasm in Reovirales.. Nucleic Acids Res 52(18):11115-11127 PMID: 39287123
- 8. Goodman J et al.. 2022. Modeling Peptide Nucleic Acid Binding Enthalpies Using MM-GBSA.. J Phys Chem B 126(46):9528-9538 PMID: 36375178
